In the burgeoning Canadian cannabis industry, the opportunities – and risks – are immense. Industry participants need sophisticated strategies to prevail in a competitive and rapidly evolving market. Drawing on our cross-disciplinary experience, we design forward-thinking solutions that drive long-term success.
From the game-changing investment by Constellation Brands in Canopy Growth to the entry of Canadian tier 1 and global investment banks into this space, our team has been at the forefront of the industry’s recent significant and groundbreaking developments. Our understanding of the cannabis space – combined with our market-leading expertise in M&A, capital markets, competition, finance, tax and restructuring – allows us to advise incisively and commercially on the full range of cannabis business matters.
That’s why key players in the sector – including early-stage startups, licensed producers, investment banks, commercial lenders, private equity firms, retailers and pharmaceutical companies – trust our team to help them successfully navigate this dynamic industry.
Our experience and reach extends to all aspects of the cannabis business, both domestically and internationally. Whether you’re a startup requiring guidance on structuring and regulatory matters, an established producer seeking growth opportunities and commercial partnerships, or a venture capital firm looking to strategically invest in the space, we work with you to achieve your business goals.
Advised the board of directors of Aleafia Health Inc., a Canadian cannabis company, in connection with an agreement between Aleafia and shareholders representing 15.6% of the shares to appoint two directors and enter into customary standstill and voting covenants.
Acted for RIV Capital Inc., an acquisition and investment company specializing in cannabis, in connection with the US$150-million strategic investment by The Hawthorne Collective, a subsidiary of The Scotts Miracle-Gro Company.
